Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for ...

After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...

AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing ...